In 2019, Hanna Andersson, a children’s apparel store, suffered a data breach while using a Salesforce e-commerce platform. As a result of the breach, customers filed a class action lawsuit, alleging customer data was stolen and asking that both Hanna Andersson and Salesforce be held liable under the California Consumer Protection Act (CCPA).
Barnes
The privacy law landscape is constantly changing, and it can feel like a daunting task for businesses to keep up with the laws of 50 states in the U.S. plus any international laws that also may be applicable. 2020 seems to be a banner year for change on many fronts. COVID-19 and the 2020 elections
One of the most reoccurring questions we’ve gotten from companies subject to CCPA that have a “Do Not Sell” link has been “What the heck do we do about this global privacy control?” Up until now, there wasn’t a clear, or even semi-helpful, answer to that question that didn’t involve a fair amount of guesswork.
Gov. Gavin Newsom recently approved A.B. 713, a bill that creates further CCPA exceptions for healthcare and research information. The bill is especially potent in the COVID-19 era where the need for medical research is greater than ever.
A.B. 713 presents a few notable changes from prior versions of the CCPA. First, the amendment expands
When California voters head to the polls on November 3, 2020, they will decide whether to approve Proposition 24 — the California Privacy Rights Act (CPRA). If approved, the act would establish new privacy rights stronger than the recently enacted landmark California Consumer Privacy Act (CCPA).
Last week, the effort to approve the CPRA gained